Can early prostate cancer screening detect genetic risk?

Question

Hello doctor,

I am a 39-year-old male with a strong family history of prostate cancer. Recent genetic testing has identified complex risk markers, which have heightened my concern about my health. My professional background drives me to seek a detailed, scientific understanding of my genetic predisposition and the most advanced risk assessment, prevention, and early intervention methods.

The uncertainty surrounding my genetic risks is causing significant stress, impacting both my personal and professional life. I am particularly interested in exploring cutting-edge genetic screening technologies, lifestyle modifications, and evidence-based medical strategies to manage my health proactively.

Kindly help.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Prostate cancer (a type of cancer that develops in the prostate gland, often growing slowly and sometimes spreading to other parts of the body) screening typically begins at age 50. However, given your family history of malignancy, it is advisable to start screening for both prostate and bowel cancer earlier. The recommended tests include:

Blood test PSA: Prostate-specific antigen test.
DRE: Digital rectal examination by a urologist.
Stool test for occult blood: To screen for bowel cancer.
Abdominal ultrasound: A comprehensive ultrasound of the entire abdomen.

To reduce the risk of prostate cancer, it is recommended to limit the consumption of red meat and animal fat while adopting a vegetarian diet. Certain foods have protective effects, including broccoli, tomatoes, green tea, soy, and vitamin E.

For genetic risk assessment, you should consider NGS (next-generation sequencing) germline multigene testing. This should include the following genes associated with prostate cancer risk: BRCA1 (breast cancer gene 1), BRCA2 (breast cancer gene 2), MSH2 and MSH6 (MutS homologs 2 and 6), MLH1 (MutL homolog 1), PMS2 (postmeiotic segregation increased 2), CHEK2 (checkpoint kinase 2), ATM (ataxia telangiectasia mutated), and PALB2 (partner and localizer of BRCA2).

Revert with the answer to assist further.

Thank you and take care.